The 30-60-90 Day Reality of Breaking Into a New Healthcare Vertical | NPLUS Global

The scenario below is a composite, built from patterns that repeat across a lot of healthcare go-to-market launches. It isn't a specific client, and the numbers are directional, not audited — but anyone who has tried to move a sales motion from one care setting into another will recognize the shape of it.

The Situation

A mid-size medical device manufacturer had a solid, mature business selling remote patient monitoring hardware into cardiology practices. New leadership decided the bigger opportunity was skilled nursing facilities — a plausible bet, given falls prevention and readmission penalties were both live pain points for that buyer. The plan was straightforward: take the existing outbound playbook, swap the target list, and run it.

Sales leadership set a 90-day target for a defined number of qualified meetings with SNF decision-makers. Marketing built a sequence. The SDR team, all trained on cardiology messaging, got a new list and a new script and started dialing.

Days 1-30: The Plan That Looked Good on Paper

Within three weeks it was clear something was off, though it took longer than it should have to diagnose why, because the early data looked like "normal outbound is hard," not "this approach is structurally wrong."

A few things surfaced once someone actually pulled the sequence apart:

The messaging didn't travel. Cardiology buyers cared about diagnostic yield and reimbursement codes. SNF administrators cared about staffing ratios, survey readiness, and family satisfaction scores. The emails were technically accurate and completely irrelevant. Reply rates were near zero, and the few replies that came in were mostly "not the right person."

"Not the right person" was doing a lot of work. In cardiology, the buying decision often sat with one or two people. In post-acute care, it was split across a director of nursing, an administrator, and — for anything with a real price tag — a regional or corporate clinical operations lead who wasn't even in the building. The team had built a one-title outreach motion for a committee-buying environment.

The list itself was a liability, not just a starting point. SNFs consolidate under regional and national operators constantly, and titles are inconsistent facility to facility — the same job might be "Administrator," "Executive Director," or "Facility Director" depending on the ownership group. A list built the same way as the cardiology list (title-match, geography, firmographic filter) produced a lot of duplicate outreach into the same corporate parent and missed the layer of decision-makers who actually controlled multi-site purchasing.

Timing assumptions were off. The cardiology cadence assumed a buyer who checks email during clinical downtime. SNF administrators are pulled into surveys, staffing fires, and family meetings constantly, and much of the operational world still runs on phone and fax more than people expect. Email-only sequencing was quietly optimizing for the wrong channel.

By day 30, the pipeline number was close to zero, and the instinct in the room was to blame execution — faster dialing, better subject lines, more volume.

Days 30-60: What Actually Changed

The real fix wasn't more effort on the same plan. It was rebuilding the target definition and the sequence around how this specific vertical actually buys.

A few concrete changes:

• The account definition shifted from facility-level to ownership-group-level. Instead of treating each SNF as its own account, the team mapped facilities up to their parent operator, then built outreach that acknowledged multi-site buying — clinical ops leads at the corporate level got a different message than on-site administrators.
• Messaging was rewritten from a survey-and-staffing lens, not a diagnostics lens. Same product, completely different framing: fewer falls, fewer hospital transfers, less documentation burden on already-stretched nursing staff.
• The sequence added phone and, in a few segments, direct mail or fax as a re-entry point, not because those channels are inherently better, but because for this buyer they weren't background noise — they still got attention.
• The team stopped chasing single-title precision and started running parallel tracks — a clinical-facing message to the DON, an operational one to the administrator, and a consolidated pitch for the corporate contact once both had been touched. It's slower to build but it matches how the actual decision gets made.
• Data hygiene became an ongoing task, not a one-time pull. Ownership changes, facility closures, and role turnover in this space happen often enough that a static list decays fast. The team treated the target list as something to refresh monthly rather than something to "finish" before launch.

Days 60-90: Where It Landed

The results weren't dramatic in a way that makes a good headline, and that's realistic. Reply rates moved from essentially nothing to a small but real trickle. Meetings went from zero to a modest, steady handful per week — enough to build an actual pipeline, not enough to declare victory. The bigger shift was qualitative: the meetings that did happen were with people who understood why the product mattered to them specifically, which meant sales conversations stopped starting with "let me explain what this is" and started with "here's how this applies to your survey cycle."

Leadership also recalibrated the 90-day target itself. The original goal had been set using cardiology benchmarks in a market where the buying committee, sales cycle, and even the calendar (Medicare cost report timing, survey windows) run differently. By day 90, the more useful metric wasn't meetings booked against an arbitrary number — it was whether the motion was repeatable enough to scale into the next region.

The Takeaway

None of this is about a smarter list or a cleverer subject line. The pattern that shows up across vertical launches — and something we at NPLUS Global see often when companies try to move an outbound motion from one care setting to another — is that teams underestimate how much the buying structure, not just the buyer's job title, changes between verticals. A 30-60-90 plan that assumes the new vertical will behave like the old one is really a 90-day plan to relearn the vertical, expensively, in public.

The version that works treats the first 30 days as discovery, not execution — get the org structure, the real decision path, and the operational calendar wrong on day 5 instead of day 45, and the next two months of the playbook write themselves.